Endometrial Cancer Staging
AI Analysis
Histology Type
Endometrioid
Serous
Clear cell
Carcinosarcoma
Undifferentiated
Mucinous
•••
Grade
Grade
1
Grade
2
Grade
3
Tumor Involvement
Endometrium, Myometrium, Serosa
Endometrium
Endometrial polyp
Myometrium •••
Uterine subserosa
or
serosa
Cervix, Parametrium, Vagina
Cervical
stroma
Cervical gland
Parametrium
Vagina
Ovary, Fallopian Tube
Ovary •••
Fallopian tube
Peritoneum, Bladder, Intestine, Distant Metastasis
Peritoneum within
pelvis (e.g. Cul-De-Sac, rectum
serosa...)
Peritoneum beyond
pelvis (e.g. Omentum, liver surface...)
Bladder mucosa
Intestinal
mucosa
Liver
Lung
Brain
Bone
Lymphovascular Space Invasion (LVSI)
Absent
Focal
Substantial
Lymph Node (LN) Status
1. Pelvic lymph node
Negative
≤0.2mm
*ITCs
>0.2-2mm
Micro-meta
>2mm
Macro-meta
2. Para-aortic lymph node
Negative
≤0.2mm
*ITCs
>0.2-2mm
Micro-meta
>2mm
Macro-meta
3. Extra- or Intra-abdominal LN above the renal vessels
Negative
Positive
*ITCs: isolated tumor cells.
Molecular Classification
1. POLE mutation status
Negative
Positive
(POLE
mutation)
Not tested
2. MMR deficiency status (MSH6, PMS2)
Negative
Positive
(MMR deficiency)
Not tested
3. p53 abnormal status
Negative
Positive
(p53 abnormal)
Not
tested
AJCC 9th
FIGO 2023
FIGO 2009
Please select the corresponding items.
Copy
Reset
ESMO Risk Group
Under construction...
Low
Risk
Risk
Intermediate
Risk
Risk
High-int.
Risk
Risk
High
Risk
Risk
Please select the corresponding pathologic status.
Ann Oncol. 2022 Sep;33(9):860-877
Management Suggestion
Under Construction